XENE
Ticker
Xenon Pharmaceuticals Inc.
XENE · Healthcare · Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therap…Xenon Pharmaceuticals Inc. (XENE), in the Healthcare sector, has 9 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 9 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 28 and filed Sep 1. The most active filer was Ian Mortimer with 6 filings.
Add to watchlistFilings, ttm
9
0 buys · 9 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$22.5M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 28
Filed Aug 31
ADViAverage daily dollar volume
$85.7M
market data
Share price · 12M
$59.75 (+60.0%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $25.5M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
IMRecent filings
Christopher John KenneySALE
Chief Medical Officer
$383K6,368 sh × $60.17
Exec Aug 28
Filed Aug 31 · 9:59 PM ET Steven GannonSALE Director $641K
10,000 sh × $64.06
Exec Aug 11
Filed Aug 13 · 4:33 PM ET Ian MortimerSALE PRESIDENT & CEO $404K
7,308 sh × $55.23
Exec Mar 13
Filed Mar 13 · 5:30 PM ET Ian MortimerSALE PRESIDENT & CEO $17.0M
281,269 sh across 10 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET Andrea DiFabioSALE Chief Legal Officer $157K
2,607 sh × $60.11
Exec Mar 10
Filed Mar 11 · 5:30 PM ET Christopher John KenneySALE Chief Medical Officer $167K
2,771 sh × $60.11
Exec Mar 10
Filed Mar 11 · 5:30 PM ET Ian MortimerSALE PRESIDENT & CEO $1.7M
37,938 sh × $44.40
Exec Jan 2
Filed Jan 2 · 5:30 PM ET Ian MortimerSALE PRESIDENT & CEO $1.0M
23,195 sh across 2 lots
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET Ian MortimerSALE PRESIDENT, CEO & INTERIM CFO $1.0M
25,000 sh × $40.16
Exec Oct 1 2025
Filed Oct 1 2025 · 5:30 PM ET Ian MortimerSALE PRESIDENT & CEO $2.2M
53,851 sh across 3 lots
Exec Jan 23 2025
Filed Jan 27 2025 · 5:30 PM ET Sherry AulinSALE Chief Financial Officer $771K
18,709 sh across 2 lots
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET Gary PatouSALE Director $117K
2,851 sh × $41.11
Exec Nov 22 2024
Filed Nov 22 2024 · 5:30 PM ET